Rather than warning doctors of side effects like suicide, GlaxoSmithKline encouraged them to prescribe Paxil to teens and children, citing their own research showing the drug was safe and effective for teens
A reanalysis of the original raw data found no evidence that Paxil was effective for the treatment of major depression in teens; its effectiveness is actually on par with placebo
It also found that serious side effects such as suicidal tendencies were mislabeled and misrepresented in the original study. Suicide was in fact 10.3 times more frequent on Paxil compared to placebo